Antibodies and COVID-19 Immunity: Testing, Limitations, and Therapies
Antibodies are immune proteins that bind to pathogens like SARS-CoV-2, neutralizing them and preventing cell infection. Understanding their role is crucial for navigating immunity, testing, and treatment options.
Role in Immunity
People who recover from COVID-19 typically develop antibodies that may protect against reinfection for several months. Some cross-reactivity with other coronaviruses, such as SARS-CoV, is also possible.
Antibody Testing
Two main types of antibody tests exist:
- Serology tests: Measure antibody levels in blood, collected via venous draw or finger prick.
- Lateral flow immunoassays: Rapid point-of-care tests using blood, saliva, or nasal fluid.
Limitations of Antibody Testing
- False positives: Cross-reactivity with other coronaviruses or recent vaccination can skew results.
- False negatives: Testing too early, before the body has produced detectable antibodies.
- Timing matters: Antibody levels fluctuate over time; an optimal testing window is needed for accuracy.
Antibody Therapies
Monoclonal antibodies—lab-produced antibodies designed to target SARS-CoV-2—have demonstrated efficacy in reducing symptom severity and preventing hospitalization. Research continues on their safety, effectiveness, and evolving role in pandemic control.
Viral Infections - Related Articles
- Virus Transmission via Contaminated Rags: Risk and Prevention
- Glandular Fever (Mono): Symptoms, Causes & Recovery
- Managing Shingles Pain: Effective Self-Care Strategies
- Comparing Global Healthcare Systems: Top-Performing Countries and Their Challenges
- Chronic Hepatitis C: Symptoms, Diagnosis & Treatment
- Viral Pneumonia: Symptoms, Risks & Diagnosis | University of Maryland Medical Center
- Why the Bubonic Plague Hasn't Returned as a Pandemic: Public Health Triumphs
